TEP

THEOPHYLLINE

Find entries where: TEP

is present as a standalone ligand in 15 entries

Find related ligands:

Chemical Component Summary
Name	THEOPHYLLINE
Identifiers	1,3-dimethyl-7H-purine-2,6-dione
Formula	C₇ H₈ N₄ O₂
Molecular Weight	180.164
Type	NON-POLYMER
Isomeric SMILES	CN1c2c([nH]cn2)C(=O)N(C1=O)C
InChI	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)
InChIKey	ZFXYFBGIUFBOJW-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	21
Chiral Atom Count	0
Bond Count	22
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB00277
Name	Theophylline
Groups	approved
Description	A methylxanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Mechanistically, theophylline acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Theophylline is marketed under several brand names such as Uniphyl and Theochron, and it is indicated mainly for asthma, bronchospasm, and COPD.
Synonyms	Theophylline anhydrous 1,3-dimethylxanthine Theophylline, anhydrous Theophylline Teofilina Theophyllin Theophylline sodium glycinate 1,3-dimethyl-7H-purine-2,6-dione
Brand Names	Slo-bid 300 Theophylline (Anhydrous) Slo-bid 200 Theophylline Theolair Tab 250mg Elixophyllin Uniphyl Idm Tab I D M Expectorant Tab Tedral Tab Theo-dur 450 mg Theophylline 0.8mg and 5% Dextrose Inj Theophylline Elixir Slo-bid 50 Senophylline Theolair SR Tab 250mg Pulmophylline Elx Quibron T SR Tab 300mg Elixir De Theophylline Teva-theophylline SR Theochron Srt 100mg Theolair Tab 125mg Theochron Srt 200mg Theolair SR Tab 500mg Theolair Theolair SR Tab 200mg Theophylline in Dextrose Theophylline(Anhydrous) Theophylline Rougier Elixir Theophylline 0.8mg/ml In 5% Dextrose Inj Theophylline Extended Release Theo-dur 300 mg Apo-theo ER Quibron T/SR Theo ER Quibron-T PMS-theophylline Elixir Theo-SR 300 Srt 300mg Theolair SR Tab 300mg Theophylline Elx Theo-dur 100 mg Theophylline 1.6mg and 5% Dextrose Inj Aa-theo LA Theophylline Anhydrous Theochron Srt 300mg Theo-dur 200 mg Slo-bid 100 Theophylline 80mg/15ml Theophylline 4mg and 5% Dextrose Inj Theo-24 Ratio-theo-bronc
Indication	For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.
Categories	Agents that reduce seizure threshold Alkaloids Anti-Asthmatic Agents Autonomic Agents Bronchodilator Agents Cardiovascular Agents Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP2E1 Substrates Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Substrates Drugs for Obstructive Airway Diseases Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Narrow Therapeutic Index Drugs Neurotransmitter Agents Peripheral Nervous System Agents Phosphodiesterase 5 Inhibitors Phosphodiesterase Inhibitors Purinergic Agents Purinergic Antagonists Purinergic P1 Receptor Antagonists Purines Purinones Respiratory Smooth Muscle Relaxants Respiratory System Agents Vasodilating Agents Xanthine derivatives Xanthines and Adrenergics
ATC-Code	R03DA54 R03DA74 R03DA20 R03DA04 R03DB04
CAS number	58-55-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Adenosine receptor A1	MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVS...	unknown	antagonist
Adenosine receptor A2a	MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAA...	unknown	antagonist
Adenosine receptor A2b	MLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLA...	unknown	antagonist
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNL...	unknown	inhibitor
cGMP-specific 3',5'-cyclic phosphodiesterase	MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKAT...	unknown	inhibitor
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSD...	unknown	inhibitor
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	MAVPGDAARVRDKPVHSGVSQAPTAGRDCHHRADPASPRDSGCRGCWGDL...	unknown	inhibitor
Histone deacetylase 2	MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYR...	unknown	activator
Copine-1	MAHCVTLVQLSISCDHLIDKDIGSKSDPLCVLLQDVGGGSWAELGRTERV...	unknown
Minor histocompatibility antigen H13	MDSALSDPHNGSAEAGGPTNSTTRPPSTPEGIALAYGSLLLMALLPIFFG...	unknown
Nodal modulator 1	MLVGQGAGPLGPAVVTAAVVLLLSGVGPAHGSEDIVVGCGGFVKSDVEIN...	unknown
Poly [ADP-ribose] polymerase 1	MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPH...	unknown
Protein RIC-3	MAYSTVQRVALASGLVLALSLLLPKAFLSRGKRQEPPPTPEGKLGRFPPM...	unknown
Tubulin monoglycylase TTLL3	MNRLRNAKIYVERAVKQKKIFTIQGCYPVIRCLLRRRGWVEKKMVHRSGP...	unknown
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	substrate,inhibitor
Cytochrome P450 1B1	MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSA...	unknown	substrate
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	substrate
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	substrate
Adenosine deaminase	MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVI...	unknown	inhibitor,inducer
Cytochrome P450 2E1	MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLEL...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Solute carrier family 22 member 7	MGFEELLEQVGGFGPFQLRNVALLALPRVLLPLHFLLPIFLAAVPAHRCA...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL190
PubChem	2153
ChEMBL	CHEMBL190
ChEBI	CHEBI:28177
CCDC/CSD	THEOCP, BUKYOX, HURPOC, KIGLOC, DEDMEH, DIPJAQ, FISNIH, LUKXUL, KIGKAN, AWIJEW, BAPLOT06, CODCOO, DOPNED, KIGLUI, DUCROJ, MEPMAY, BAPLOT02, LEDVOH, BAPLOT03, DUXZAX, HOCCUZ, KIGLES, HUMNEK01, KIGLUI01, DEYREF, DOXFIH, HEBFIF, BAPLOT01, DOPMUS, KICWIE, EVEYAH, DOPNAZ, DUWXAW, HINTOQ, CIZTAH, NEHJER, GAFTUE, HEBFEB, KAMQIB, IJIBEJ, HUMNEK, KIGLIW, KIGLES01, BAPLOT05, CSATEO, BAPLOT04, IJIBEJ01, GEKMUH, HUHQIN01, BAPLOT09
COD	4510940, 7212475, 2235895, 4500220, 4500221, 4511895, 4511896, 4511897, 4511899, 4511900, 7201986, 2018307, 4513335, 4513785, 4513786, 4513787, 4513790, 4513791, 4513792, 2212751, 7215947, 7215948, 7215949, 7215951, 7215952, 7215953, 2223173, 2232996, 2020422, 4505532, 4505533, 2214180, 2021130, 7229994, 7229995, 7229997, 7229998, 7229999, 2311903, 7220330, 1505175, 1505177, 1505185

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

TEP

THEOPHYLLINE

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References